NOK251.00
2.45% today
Oslo, Sep 17, 09:00 am CET
ISIN
NO0010159684
Symbol
MEDI

Medistim Stock price

NOK245.00
+20.00 8.89% 1M
+57.00 30.32% 6M
+95.50 63.88% YTD
+66.00 36.87% 1Y
+44.00 21.89% 3Y
+7.00 2.94% 5Y
+200.50 450.56% 10Y
+235.34 2,435.18% 20Y
Oslo, Closing price Tue, Sep 16 2025
+2.00 0.82%
ISIN
NO0010159684
Symbol
MEDI

Key metrics

Basic
Market capitalization
NOK4.4b
Enterprise Value
NOK4.4b
Net debt
positive
Cash
NOK96.4m
Shares outstanding
18.3m
Valuation (TTM | estimate)
P/E
34.2 | 34.5
P/S
7.0 | 6.7
EV/Sales
6.9 | 6.6
EV/FCF
28.6
P/B
11.5
Dividends
DPS
NOK6.00
Yield 1Y | 5Y
2.5% | 1.8%
Growth 1Y | 5Y
33.3% | 16.9%
Payout 1Y | 3Y
105.8% | 85.3%
Increased
1 Year
Financials (TTM | estimate)
Revenue
NOK634.5m | NOK655.9m
EBITDA
NOK194.7m | NOK157.1m
EBIT
NOK171.1m | NOK173.4m
Net Income
NOK131.1m | NOK129.7m
Free Cash Flow
NOK152.2m
Growth (TTM | estimate)
Revenue
17.9% | 16.6%
EBITDA
26.3% | 1.0%
EBIT
32.5% | 32.3%
Net Income
25.7% | 24.9%
Free Cash Flow
18.5%
Margin (TTM | estimate)
Gross
80.9%
EBITDA
30.7% | 24.0%
EBIT
27.0%
Net
20.7% | 19.8%
Free Cash Flow
24.0%
Financial Health
Equity Ratio
75.9%
Return on Equity
23.8%
ROCE
41.6%
ROIC
-
Debt/Equity
0.1
More
EPS
NOK7.2
FCF per Share
NOK8.3
Short interest
-
Employees
154
Rev per Employee
NOK3.7m
Show more

Is Medistim a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,016 stocks worldwide.

Medistim Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Medistim forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Medistim forecast:

Buy
75%
Hold
25%

Financial data from Medistim

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
635 635
18% 18%
100%
- Direct Costs 121 121
10% 10%
19%
514 514
20% 20%
81%
- Selling and Administrative Expenses 206 206
18% 18%
32%
- Research and Development Expense - -
-
-
195 195
26% 26%
31%
- Depreciation and Amortization 24 24
6% 6%
4%
EBIT (Operating Income) EBIT 171 171
33% 33%
27%
Net Profit 131 131
26% 26%
21%

In millions NOK.

Don't miss a Thing! We will send you all news about Medistim directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. It operates through the following segments: Lease of Equipment, Capital Sales/Consumables, and Third Party Products. The Lease of Equipment segment delivers system and probes at the customer site free of charge. The Capital Sales/Consumables segment consists of probe sales, lease, and PPP cards. The Third Party Products segment offers products related with surgery. Its products include MiraQ Cardiac, MiraQ Vascular, MiraQ Ultimate, Imaging Probe, and Flow Probe. The company was founded by Kari Mette Tjolsen Pah on June 10, 1984 and is headquartered in Oslo, Norway.

Head office Norway
CEO Kari Krogstad
Employees 154
Founded 1984
Website medistim.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today